Related by context. All words. (Click for frequent words.) 72 developing VLP vaccines 65 recombinant vaccine 62 pandemic influenza strains 60 VLP vaccine 60 H#N# influenza virus 60 influenza VLP vaccine 60 oseltamivir resistant 59 M2e 59 serum antibody 59 nonvaccine serotypes 59 nucleotide analog 59 H#N# VLP vaccine 59 pertussis tetanus 59 pandemic influenza virus 59 H#N# influenza 58 neuraminidase inhibitor 58 paralytic poliomyelitis 58 BRSV 58 A/H#N# pandemic influenza 58 recurrent genital herpes 58 A/H#N# strain 58 intranasal influenza 57 influenza virus 57 VLP vaccine candidate 57 monovalent vaccine 57 H#N# Avian Influenza 57 Thiovir 57 trivalent influenza vaccine 57 TransVax TM 57 plague bacterium Yersinia 57 WNV infection 57 varicella zoster virus VZV 57 pandemic influenza 57 S. suis 57 novel H#N# influenza 57 pandemic H#N# virus 57 HBV vaccine 57 influenza 57 influenza subtypes 56 recombinant subunit vaccine 56 CCR5 tropic 56 Acute Radiation Syndrome ARS 56 Vaxfectin ® 56 multivalent vaccine 56 avian H#N# influenza 56 RiVax 56 parainfluenza virus 56 HIN1 virus 56 vaccine serotypes 56 pneumococcal serotypes 56 Candida species 56 Multimeric 56 subunit vaccine 56 live attenuated vaccines 56 Dengue virus 56 b Hib 56 H#N# avian 56 P. vivax malaria 56 seasonal influenza 56 H#N# monovalent vaccine 56 pandemic influenza viruses 56 Hepatitis B Virus 56 Intercell vaccine 56 neutralizing antibody 56 Vaxfectin TM formulated 56 H#N# Influenza virus 56 HPAI H#N# 56 Cytomegalovirus CMV 56 H#N# swine flu 56 dengue viruses 56 WNV infections 56 serogroup B 56 Japanese encephalitis JE 55 nuclease degradation 55 conjugate vaccine 55 influenza A/H#N# virus 55 antigen rPA anthrax 55 CHIKV 55 HPV Human Papillomavirus 55 Inactivated 55 influenza antiviral medications 55 virus subtype 55 N. meningitidis 55 B Anflu R 55 varicella zoster virus 55 nonvaccine 55 recombinant hepatitis B 55 LEAPS TM 55 inactivated influenza vaccine 55 replicon 55 im peramivir 55 methicillin resistant MRSA 55 swine influenza 55 Japanese Encephalitis JE 55 Sinovac vaccine 55 ROTATEQ 55 attenuated strain 55 Modified Vaccinia Ankara 55 influenza subtype 55 pandemic H#N# influenza 55 CCR5 mAb 55 Altastaph 55 tetravalent vaccine 55 pandemic influenza vaccine 55 postexposure prophylaxis 55 bacterium Neisseria meningitidis 55 conserved antigens NP 55 inactivated influenza 55 intravenous iv 55 H#N# viruses 55 avian influenza H#N# 55 GeoVax vaccine 55 chlamydial 55 oseltamivir resistance 55 TCAD therapy 55 Hepatitis C virus HCV 55 MenACWY 55 vaccine LAIV 55 Vaxfectin 55 Human cl 55 A/H#N# influenza virus 55 Smallpox vaccines 55 Pandemic H#N# 55 highly pathogenic influenza 55 S OIV 55 CCR5 tropic HIV 54 live attenuated influenza 54 inactivated vaccine 54 H#N# influenza strain 54 PCV7 vaccine 54 enterotoxigenic E. coli ETEC 54 A/H#N# flu pandemic 54 prophylactic vaccine 54 E. coli STEC 54 A/H#N# influenza 54 H#N# flu 54 valent pneumococcal conjugate vaccine 54 rotavirus gastroenteritis 54 GeoVax HIV AIDS 54 Streptococcus pneumonia 54 pandemic H#N# 54 pandemic influenza vaccines 54 Modified Vaccinia Ankara MVA 54 herpes zoster virus 54 rotaviruses 54 hepatitis B infection 54 Swine influenza 54 H5 influenza 54 Staphylococcus aureus infections 54 viral strains 54 PREVENAR 54 pneumococcal infection 54 MenB 54 intranasal influenza vaccine 54 LAIV 54 influenza strains 54 Flavivirus 54 enterotoxigenic E. coli 54 HAV infection 54 Pandemic Influenza Vaccine 54 MVA BN ® 54 adjuvanted vaccines 54 MF# adjuvanted 54 virus RSV 54 DAS# [001] 54 oseltamivir Tamiflu 54 trivalent inactivated influenza 54 chronic HBV infection 54 seasonal influenza vaccine 54 dengue serotype 54 commonly infect humans 54 neutralizing antibodies 54 H#N# pandemic 54 mutated virus 54 serogroup C 54 Novavax trivalent seasonal influenza 54 H#N# Swine flu 54 inactivated strain 54 Vaxfectin adjuvant 54 cervical vulvar 54 Valortim R 54 H#N# Swine Flu 54 adenovirus vector 54 4 6B 9V 54 A/H#N# flu virus 54 influenza VLP vaccines 54 Varicella 54 VZV 54 H1NI 54 MVA BN R 54 SparVax ™ 54 bacterial respiratory infections 54 diphtheria tetanus pertussis 54 viral antigen 54 CMV vaccine 54 Salmonella typhi 54 PENNVAX B 54 Like Illness ILI 54 inhalational anthrax 54 Shiga toxin producing 54 DepoVax 54 adenovirus serotype 5 53 Virological 53 TransVax ™ 53 TransVax 53 FLU v 53 H5 strains 53 Novel Influenza 53 H#N# avian influenza 53 H#N# influenza vaccines 53 ROTARIX 53 CELVAPAN H#N# 53 combination antiretroviral therapy 53 postexposure 53 Vaxfectin TM adjuvant 53 recurrent glioma 53 rotavirus infection 53 influenza viruses circulating 53 Rimantadine 53 CCR5 antagonist 53 pH#N# 53 humoral responses 53 M#V mutation 53 anti idiotype 53 PCV7 53 antigen sparing 53 Twinrix 53 R5 tropic 53 EV# vaccine 53 virosome 53 GelVac TM 53 immunosuppressed patients 53 Chlamydia trachomatis 53 BARACLUDE R 53 bioterrorist weapon 53 Cytolin R 53 PPSV# 53 heterologous 53 bacillary dysentery 53 Vaxigrip 53 vancomycin resistant 53 highly pathogenic H#N# avian 53 simian foamy virus 53 severe oral mucositis 53 simplex virus 53 varicella virus 53 human immunodeficiency virus 53 AdVac ® 53 Highly Pathogenic 53 circulating influenza viruses 53 potent cytotoxic 53 ChimeriVax JE 53 serotype #A 53 Hepatitis C Virus HCV 53 NEUMUNE 53 viral isolates 53 arboviruses 53 A/H#N# pandemic 53 intranasal vaccine 53 oral poliovirus 53 human metapneumovirus 53 varicella zoster 53 influenza AH#N# 53 paratyphoid fever 53 dual tropic 53 antiviral efficacy 53 Haemophilus influenza 53 methicillin susceptible Staphylococcus aureus 53 Epstein Barr Virus EBV 53 P. falciparum malaria 53 Klebsiella pneumonia 53 monovalent oral polio vaccine 53 Fluzone vaccine 53 transgenic rats 53 oncogenic HPV 53 Cytolin ® 53 reassortant viruses 53 KINRIX 53 topical microbicides 53 H#N# Avian Flu 53 NNRTI resistant virus 53 H#Y mutation 53 CERVARIX 53 influenza A/H#N# 53 dengue leptospirosis 53 SIV infection 53 WNv 53 OncoVEX 53 AH#N# influenza 53 Menactra vaccine 53 shingles herpes zoster 53 herpes zoster shingles 53 Vaccine Candidate 53 surface antigen HBsAg 53 serotype 53 Novel H#N# influenza 52 Hepatitis C virus 52 respiratory syncytial virus 52 IMVAMUNE TM 52 Adenovirus 52 pandemic influenza A/H#N# 52 ImmunoVEX HSV2 52 Chikungunya virus 52 Respiratory syncytial virus 52 vaccine TIV 52 ZOSTAVAX 52 swine origin 52 tuberculin skin testing 52 Avian influenza H#N# 52 Antiviral drugs 52 valent pneumococcal 52 genital herpes infections 52 whooping cough pertussis 52 neutralizing antibody responses 52 IMVAMUNE 52 Ixiaro 52 avian strains 52 Imvamune R 52 K ras mutations 52 hemorrhagic fever viruses 52 Salmonella Typhi 52 Adjuvanted 52 Respiratory Syncytial Virus RSV 52 ketolide antibiotic 52 enterovirus infections 52 severe rotavirus gastroenteritis 52 pathogenic viruses 52 Valortim 52 external genital lesions 52 H#N# virus 52 attenuated smallpox vaccine 52 Valortim ® 52 vector adenovirus serotype 52 Vivotif ® 52 avian strain 52 swine influenza A/H#N# 52 non adjuvanted vaccines 52 HCV genotypes 52 dengue haemorrhagic fever DHF 52 replikin 52 nucleoside analog 52 Fludase 52 Marburg haemorrhagic fever 52 LC#m# 52 toxoid 52 intramuscular vaccination 52 Clostridium difficile C. difficile 52 Varicella zoster virus 52 serogroups 52 chemotherapy induced neutropenia 52 H7 virus 52 H5 avian 52 parainfluenza 52 nanoviricides 52 trivalent vaccine 52 Ampligen ® 52 T. cruzi 52 tigecycline 52 lopinavir ritonavir Kaletra 52 7 valent Conjugate 52 bacteria Streptococcus pneumoniae 52 seasonal influenza strains 52 FluCide 52 H#N# Influenza 52 NRTI resistance 52 vaccinia virus 52 VLP influenza 52 Influenza Virus 52 S. aureus infections 52 Pentacel R 52 H. influenzae 52 highly pathogenic strains 52 HPV subtypes 52 serogroup 52 attenuated vaccine 52 antiviral prophylaxis 52 antiviral 52 Pentacel vaccine 52 CMV reactivation 52 viral pathogens 52 CBLC# 52 H7 viruses 52 Varicella chicken pox 52 H1N 52 dose intramuscular 52 non nucleoside HCV 52 Radilex 52 Burkholderia pseudomallei 52 H#N# avian flu 52 cryptococcal meningitis 52 Roche Holding Tamiflu 52 H#N#virus 52 prepandemic 52 H#N# 52 rPA anthrax vaccine 52 Haemophilus Influenzae 52 diarrhea BVD 52 measles mumps rubella varicella 52 orthopoxvirus 52 whooping cough polio 52 H7 avian flu 52 HIN1 52 administered prophylactically 52 forodesine 52 Streptococcus pneumoniae bacteria 52 adjuvanted H#N# 52 SynCon ™ DNA 52 highly pathogenic H#N# influenza 52 H7 subtypes 52 polysaccharide vaccines 52 Human Papilloma Virus HPV 52 antibody titers 52 avian influenza virus 52 oncolytic virus 52 oral prodrug 52 acyclovir valacyclovir 52 AH#N# 52 rotavirus strains 52 acute respiratory tract infections 52 serologic 52 Staphylococcus aureus MRSA 52 CD8 responses 52 Haemophilus 52 attenuated weakened 52 varicella 52 solithromycin 52 parainfluenza viruses 52 Human papillomavirus HPV 52 Bordetella pertussis 52 WNV 52 discontinued Viread 52 pandemic influenza H#N# 52 pneumococcal conjugate 52 Human Papillomavirus 51 Serologic 51 Dengue hemorrhagic fever 51 febrile illness 51 Human Papilloma Virus 51 fluoroquinolone resistance 51 nonpharmaceutical interventions 51 serologic testing 51 Vancomycin resistant 51 avian H#N# 51 virus HBV 51 inactivated hepatitis 51 S. pyogenes 51 Gag polymorphisms 51 Alferon N 51 bivalent vaccine 51 Novartis MenB vaccine 51 bivalent oral polio vaccine 51 pneumococcal pneumonia 51 investigational hepatitis B 51 Bilive R 51 clade B 51 VIR# 51 peptide antigens 51 A/H#N# 51 rFIXFc 51 Aflunov 51 subtype H#N# 51 H5NI strain 51 vaccine Menactra 51 avian H#N# virus 51 avian influenza AI 51 dengue epidemics 51 meningococcus 51 Influenza A/H#N# 51 Ligand Epitope Antigen Presentation 51 quadrivalent HPV vaccine 51 VLPs 51 NEUGENE 51 induces antibodies 51 immunogenicity 51 herpesviruses 51 prion infections 51 Immune globulin 51 virus AAV 51 PEGylated 51 Alinia 51 nasal powder 51 linezolid resistant 51 H5 N1 51 Serotype 51 hepatitis B immunoglobulin 51 avian influenza bird flu 51 ImmunoVEX 51 enterovirus infection 51 Candida infection 51 PREVNAR 51 SparVax TM 51 Bcr Abl mutations 51 Tamiflu resistant strains 51 wild poliovirus 51 SynCon 51 N#H# virus 51 cerebrospinal meningitis 51 trivalent seasonal influenza 51 Equine piroplasmosis 51 vero cell 51 virus 51 Cryptococcus neoformans 51 TTR gene 51 cytomegalovirus CMV 51 Staphylococcus epidermidis 51 injectable influenza 51 intranasal mist 51 R Influenza Virus 51 suppressive therapy 51 chemoprophylaxis 51 Pseudomonas aeruginosa infections 51 Highly pathogenic 51 Epstein Barr virus EBV 51 AH#N# virus 51 EBV infection 51 proguanil 51 nosocomial transmission 51 zoster vaccine 51 Bluetongue virus 51 vesicular stomatitis virus 51 Swine Influenza 51 MVA nef 51 Neisseria meningitidis 51 coccidiosis 51 Varicella Zoster 51 viral subtypes 51 VRSA 51 topical microbicide 51 Menveo 51 Traficet EN 51 wild poliovirus type 51 dependent cellular cytotoxicity 51 telbivudine 51 AEG# 51 Ebola Marburg 51 conjugate vaccines 51 polioviruses 51 DNA plasmids 51 low pathogenic strains 51 adamantanes 51 Anflu 51 H7 influenza 51 pneumonia tetanus 51 Hib disease 51 PREFLUCEL 51 acute febrile 51 Plasmodium falciparum malaria 51 PCV1 51 disease CDAD 51 rhinotracheitis 51 zanamivir Relenza 51 S. enterica 51 influenza outbreaks 51 H7 avian influenza 51 zoster 51 superantigens 51 IXIARO 51 latent tuberculosis infection 51 viral respiratory infections 51 specific CD8 + 51 immunostimulatory 51 V. cholerae 51 variola 51 dengue virus 51 SynCon ™ 51 Paratuberculosis para TB 51 avian influenzas 51 Trichomonas vaginalis 51 adenovirus infection 51 highly immunogenic 51 Neisseria gonorrhoeae 51 transfusion transmitted 51 H5 viruses 50 methicillin susceptible MSSA 50 H#N# influenza pandemic 50 reemerging infectious diseases 50 precancerous cervical lesions 50 inactivated polio vaccine 50 simian human immunodeficiency 50 IgM antibodies 50 P. falciparum parasites 50 DEB# 50 rifabutin 50 using Crucell PER.C6 50 Japanese Encephalitis 50 ACAM# 50 Hendra viruses 50 efalizumab 50 Escherichia coli Klebsiella pneumoniae 50 influenza antivirals 50 HN# strain 50 S. pneumoniae 50 PCV2 50 naive HCV 50 Humenza 50 Anflu R 50 HCV infection 50 MCV4 50 XDR tuberculosis 50 HBsAg 50 receptor specificity 50 HER2/neu 50 diphtheria toxoid 50 Sudden Acute Respiratory Syndrome 50 H#N# swine 50 Pentavalent 50 HPV-#/# 50 rotavirus diarrhea 50 OncoVEX GM CSF 50 nelfinavir Viracept 50 rabies chickenpox mumps 50 Acellular Pertussis Adsorbed 50 GABHS 50 particle VLP vaccine 50 thiazolides 50 Diphtheria 50 surface proteins hemagglutinin 50 Influenza A/H#N# virus 50 velafermin 50 chikungunya virus 50 virus HCV infection 50 KETEK 50 pertussis whooping cough 50 reassortant 50 quadrivalent vaccine 50 hepatitis B virus HBV 50 undetectable hepatitis C 50 Swine flu viruses 50 acellular pertussis DTaP 50 Avian Flu Virus 50 Salmonella spp 50 parasite Plasmodium falciparum 50 superinfection 50 Blinatumomab 50 bacterium Mycobacterium tuberculosis 50 Tetanus Toxoids 50 Japanese Encephalitis Vaccine 50 antibody responses 50 parasite Trypanosoma cruzi 50 Guillain Barre Syndrome GBS 50 immunomodulators 50 Telbivudine 50 human rhinovirus HRV 50 CXB# 50 H#N# influenza vaccine 50 AH#N# flu 50 poliovirus vaccine 50 pneumococcus bacteria 50 foodborne infections 50 quinolone 50 Inflexal ® V 50 Bilive R combined 50 invasive meningococcal disease 50 Neisseria meningitides 50 cervical HPV 50 Trypanosoma brucei 50 Y. pestis 50 protease inhibitors PIs 50 Inavir 50 oncolytic 50 immunopathology 50 P aeruginosa 50 H#N# Flu Virus 50 cidofovir 50 Staphylococcal 50 hepatitis C virus 50 monovalent 50 pneumococci 50 fungal meningitis 50 MeNZB ™ 50 seasonal influenza viruses 50 dengue hemorrhagic fever 50 telaprevir VX 50 amantadine Symmetrel 50 S Typhi 50 intravenous iv peramivir 50 CTAP# Capsules 50 paramyxoviruses 50 pestis 50 MVA BN 50 dengue hemorrhagic fever DHF 50 Streptococcus pneumoniae pneumococcus 50 H#N# influenza viruses 50 hemagglutinin HA 50 Cerebro Spinal Meningitis CSM 50 AAV vector 50 Influenza Type 50 low pathogenicity avian 50 herpes zoster 50 virotherapy 50 MenB strains 50 paralytic polio 50 SARS CoV 50 Neugene 50 foodborne bacterial 50 Viprovex 50 ADACEL vaccine 50 A/H#N# virus 50 Staphylococcus aureus Polysaccharide Conjugate 50 pneumocystis 50 hepatitis C HCV 50 persistent fever cough 50 seroprotection 50 diphtheria pertussis tetanus 50 BAL# [001] 50 antiviral therapies 50 fully liquid pentavalent 50 lymphogranuloma venereum 50 HepaGam B TM 50 virologic 50 serotypes 50 carbapenem resistant Klebsiella pneumoniae 50 H5NI bird flu 50 ancient retrovirus 50 Avian Influenza H#N# 50 chickenpox varicella 50 deadly Marburg virus 50 Invasive fungal infections 50 HBeAg negative 50 TLR9 agonist 50 selective orally bioavailable 50 investigational integrase inhibitor 50 E. faecalis 50 Extensively drug 50 latent tuberculosis 50 mucocutaneous reactions 50 Plasmodium vivax 50 Pandemic Influenza H#N# 50 MYCAMINE 50 Hepatitis C HCV 50 humoral immunity 50 immunized mice 50 rotavirus 50 toxoids 50 invasive pneumococcal 50 methicillin susceptible 50 Hemagglutinin 50 nucleotide analogue 50 post surgical adhesions 50 Telintra 50 Helicobacter pylori H. pylori 50 Tetanus diphtheria 50 Sanofi Pasteur Fluzone 50 alphavirus 50 artemisinin resistance 50 HQK 50 Tamiflu Relenza 50 HIV coinfected 50 influenza pandemic 50 amebiasis 50 tetanus polio 50 H#Y 50 kidney urologic 50 Tarvacin TM 50 virus SIV 50 live attenuated intranasal 50 virulent H#N# 50 RELENZA 50 BARACLUDE ® 50 diphtheria pertussis 50 influenza vaccine 49 H5 H7 49 Vaccine Diphtheria CRM# Protein 49 CYT# 49 7 valent pneumococcal 49 influenzalike illness 49 4CMenB 49 P. falciparum 49 H#N# Influenza Virus 49 HINI 49 NS#/#A protease 49 HTS assay 49 rubella hepatitis 49 H5 avian flu 49 vaccinia 49 NNRTIs 49 CLORETAZINE TM VNP#M 49 proprietary VLP 49 cryptococcosis 49 polio whooping cough 49 Panflu 49 BioVant 49 vaginal cancers 49 Genital herpes 49 CYC# 49 Plasmodium ovale 49 Tindamax R 49 acellular pertussis 49 vaccinees 49 Vesivirus 49 mosquito transmitted 49 indinavir 49 pasteurella 49 pertussis toxin 49 BioSante 2A/Furin technology 49 Methicillin resistant 49 Herpes zoster 49 vibrio parahaemolyticus bacteria 49 vidofludimus 49 oral antiviral 49 rhinovirus infection 49 Influenza Virus Vaccine 49 JVRS 49 DENV 49 eppin 49 quinolone resistant 49 immunotoxins 49 Respiratory Syncytial Virus 49 AV HALT 49 Bavituximab 49 pandemic influenza strain 49 WEST NILE 49 interferon beta 49 Tarvacin 49 chronic hepatitis B. 49 recombinant interferon 49 Pentacel 49 chronic HCV infection 49 meningococcal bacteria 49 simian immunodeficiency virus 49 IMA# 49 Relenza zanamivir 49 Hepatitis E 49 influenza pandemics 49 Varicella vaccine 49 vibrio cholera 49 NS4A 49 Salmonella Campylobacter 49 oseltamivir 49 plasmid DNA vaccine 49 antiviral therapy 49 BCG vaccine 49 Quinvaxem R 49 streptococcus pneumoniae 49 Nitazoxanide 49 reverse vaccinology 49 Typhimurium 49 diarrheal illness 49 selective modulator 49 cowpox virus 49 Hib vaccines 49 Respiratory syncytial virus RSV 49 protease inhibitor PI 49 bacteria Mycobacterium tuberculosis 49 Neisseria meningitidis serogroups 49 adamantane drugs 49 CMV infection 49 bacterial fungal 49 emergent strains 49 invasive candidiasis 49 Dalbavancin 49 Influenza viruses 49 capsular polysaccharide 49 herpes labialis 49 artus 49 Cytotoxic T 49 Mycobacterium tuberculosis TB 49 zanamivir 49 Cytomegalovirus 49 H#N# isolates 49 Salmonella enterica 49 MenC 49 pertusis 49 nucleoside analogues 49 falciparum 49 influenza viruses 49 adenovector 49 VLP vaccines 49 BTV8 49 pneumococcal bacteria 49 Pediarix 49 non nucleoside 49 HCV polymerase inhibitor 49 respiratory viral infections 49 Escherichia coli O# 49 invasive aspergillosis 49 H5NI 49 anal HPV 49 potent antiviral 49 cervical vaginal 49 polymerase inhibitors 49 Acellular Pertussis Vaccine Adsorbed 49 intradermal delivery 49 PCVAD 49 oseltamivir Tamiflu ® 49 FluCide HP 49 Prevenar 49 meningoencephalitis 49 investigational monoclonal antibody 49 Marburg hemorrhagic fever 49 chlamydial infections 49 Amantadine 49 diphtheria whooping cough tetanus 49 murine leukemia virus 49 Xanafide 49 A/Vietnam/#/# 49 LTBI 49 Measles Mumps 49 vaccine antigens 49 Shigella 49 diptheria tetanus 49 innate immune responses 49 immunomodulator 49 rhinovirus infections 49 N. gonorrhoeae 49 Pandemic Flu Vaccine 49 H#N# subtype 49 pharmacokinetic interactions 49 Ebola hemorrhagic fever 49 sorafenib tablets 49 tetanus measles 49 Streptococcus pneumoniae 49 Virus Vaccine 49 Ankara MVA 49 Gammagard Liquid 49 nanoviricide 49 neuraminidase inhibitors 49 Venezuelan equine encephalitis 49 highly pathogenic H#N# 49 hMPV 49 GlaxoSmithKline Plc Relenza 49 Panenza 49 avian influenza pandemic 49 respiratory viruses 49 Enterococcus faecalis vancomycin susceptible 49 myopericarditis 49 Enterobacter cloacae 49 C. gattii 49 Swine Flu H#N# 49 seasonal influenza vaccination 49 erlotinib Tarceva ® 49 MenACWY CRM 49 Adeno 49 mOPV1 49 candidemia 49 seasonal influenza outbreaks 49 tickborne 49 nanoviricides ® 49 Interferon alpha 49 herpes zoster vaccine 49 erythropoietic 49 menadione 49 arbovirus 49 humanized monoclonal antibodies 49 DepoVax TM 49 latently infected 49 bacillus Calmette Guerin BCG 49 unadjuvanted vaccines 49 Flu Mist nasal spray 49 flu virus 49 EGFR TKIs 49 Panflu TM H#N# 49 recombinant vaccines 49 myelofibrosis polycythemia vera 49 antiviral drug 49 TRIM5a 49 S aureus 49 hemorrhagic cystitis 49 VivaGel TM 49 Avian Influenza Virus 49 Plasmodium falciparum parasite 49 HCV replicon 49 diphtheria tetanus pertussis polio 49 botulinum neurotoxin 49 infectious gastroenteritis 49 Td tetanus 49 biodefense pathogens 49 IRX 2 49 OHR/AVR# 49 highly pathogenic H#N# virus 49 viral hemorrhagic fevers 49 sJIA 49 mumps rubella 49 bortezomib Velcade 49 CCR5 receptor antagonist 49 PRTX 49 tetanus diptheria 49 Anaplasma 49 intradermal injection 49 H1 H3 49 ESBL producing E. coli 49 Shigella bacteria 49 Staphylococci 49 ano genital warts 49 Rotarix vaccine 49 M#V 49 viruses mutate 49 Toxoid 49 invasive fungal infections 49 influenza vaccines 49 busulfan 49 arthropod borne 49 bivalent 49 aT cell 49 ABSSSI 49 Afluria 49 GRNVAC1 48 Mycobacterium bovis 48 valacyclovir Valtrex